Jeito Capital leads €75m investment in NMD Pharma
Healthcare investment firm Jeito Capital has led a €75m series-B financing in NMD Pharma.
The Denmark-based firm is a clinical-stage biotech developing treatments for neuromuscular diseases.
Healthcare investment firm Jeito Capital has led a €75m series-B financing in NMD Pharma.
The Denmark-based firm is a clinical-stage biotech developing treatments for neuromuscular diseases.